Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Frederick Wooten

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Muscle & Nerve|October 9, 2009
Central nervous system involvement in axonal Charcot-Marie-Tooth diseaseXinli Du, G Frederick Wooten, Julie A Matsumoto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2010
Handedness and motor symptom asymmetry in Parkinson's diseaseMatthew J Barrett, Scott A Wylie, Madaline B Harrison, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2015
Relationship of age of onset and family history in Parkinson diseaseMatthew J Barrett, Nicholas E Hac, Guofen Yan, et al.
Archives of Neurology|June 24, 2004
Postmenopausal estrogen use affects risk for Parkinson diseaseLillian J Currie, Madaline B Harrison, Joel M Trugman, et al.
Parkinson'S Disease|March 12, 2014
Mortality in levodopa-treated Parkinson's diseaseJohn C Morgan, Lillian J Currie, Madaline B Harrison, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|November 15, 2017
Capgras Syndrome in Advanced Parkinson's DiseaseChristopher L Groth, Antonia Pusso, Scott A Sperling, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2008
UPDRS activity of daily living score as a marker of Parkinson's disease progressionMadaline B Harrison, Scott A Wylie, Robert C Frysinger, et al.
Behavioral Neuroscience|May 25, 2011
The risky business of dopamine agonists in Parkinson disease and impulse control disordersDaniel O Claassen, Wery P M van den Wildenberg, K Richard Ridderinkhof, et al.
The Lancet. Neurology|February 21, 2006
GDNF in treatment of Parkinson's disease: response to editorialAnthony E Lang, J William Langston, A Jon Stoessl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophyLaurie J Ozelius, Tatiana Foroud, Susanne May, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Muscle & Nerve|October 9, 2009
Central nervous system involvement in axonal Charcot-Marie-Tooth diseaseXinli Du, G Frederick Wooten, Julie A Matsumoto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2010
Handedness and motor symptom asymmetry in Parkinson's diseaseMatthew J Barrett, Scott A Wylie, Madaline B Harrison, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2015
Relationship of age of onset and family history in Parkinson diseaseMatthew J Barrett, Nicholas E Hac, Guofen Yan, et al.
Archives of Neurology|June 24, 2004
Postmenopausal estrogen use affects risk for Parkinson diseaseLillian J Currie, Madaline B Harrison, Joel M Trugman, et al.
Parkinson'S Disease|March 12, 2014
Mortality in levodopa-treated Parkinson's diseaseJohn C Morgan, Lillian J Currie, Madaline B Harrison, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|November 15, 2017
Capgras Syndrome in Advanced Parkinson's DiseaseChristopher L Groth, Antonia Pusso, Scott A Sperling, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2008
UPDRS activity of daily living score as a marker of Parkinson's disease progressionMadaline B Harrison, Scott A Wylie, Robert C Frysinger, et al.
Behavioral Neuroscience|May 25, 2011
The risky business of dopamine agonists in Parkinson disease and impulse control disordersDaniel O Claassen, Wery P M van den Wildenberg, K Richard Ridderinkhof, et al.
The Lancet. Neurology|February 21, 2006
GDNF in treatment of Parkinson's disease: response to editorialAnthony E Lang, J William Langston, A Jon Stoessl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophyLaurie J Ozelius, Tatiana Foroud, Susanne May, et al.
Pageof 3